Want to see HK:6078 full AI Analyst Report?
Hygeia Healthcare Holdings Co., Ltd. (6078) AI Stock Analysis
Top Page
Hygeia Healthcare Holdings Co., Ltd.
(HKEX:6078)
The score is primarily held back by the pronounced 2025 profitability/ROE decline despite strong multi-year revenue growth and improving cash flow. Technically, the stock shows better near-term momentum but remains below the 200-day moving average, keeping the trend signal mixed. Valuation is a headwind given the ~31 P/E with no dividend yield provided.
Hygeia Healthcare Holdings Co., Ltd. (6078) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 5.78B
- Dividend Yield
- ―
- Average Volume (3M)
- 1.68M
- Price to Earnings (P/E)
- 27.8
- Beta (1Y)
- 0.87
- Revenue Growth
- 1.59%
- EPS Growth
- -58.55%
- Country
- Hong Kong
- Employees
- 8,026
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Hygeia Healthcare Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
Hygeia Healthcare Holdings Co., Limited (6078.HK) is a prominent oncology healthcare provider primarily operating across the People's Republic of China. The company owns and manages a network of private, for-profit hospitals specializing in comprehen...
How the Company Makes Money
Hygeia Healthcare Holdings generally makes money by delivering fee-based healthcare services through its hospitals and clinics. Key revenue streams typically include: (1) Inpatient services (e.g., hospital stays, surgeries, nursing care, use of opera...
Hygeia Healthcare Holdings Co., Ltd. Financial Statement Overview
Summary
Strong multi-year revenue growth and a generally manageable leverage profile are positives, and operating cash flow improved with a free-cash-flow rebound in 2025. However, the sharp 2025 profitability and ROE deterioration (net margin down to ~4.1% from ~13.5% in 2024) meaningfully reduces earnings quality and consistency.
Income Statement
62PositiveBalance Sheet
70PositiveCash Flow
66Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.98B | 4.01B | 4.45B | 4.08B | 3.20B | 2.32B |
| Gross Profit | 1.03B | 1.02B | 1.33B | 1.27B | 1.02B | 744.66M |
| EBITDA | 929.26M | 988.03M | 1.12B | 1.08B | 888.95M | 640.05M |
| Net Income | 174.87M | 164.53M | 598.26M | 682.93M | 476.78M | 441.46M |
Balance Sheet | ||||||
| Total Assets | 10.60B | 10.67B | 10.93B | 10.73B | 7.24B | 6.69B |
| Cash, Cash Equivalents and Short-Term Investments | 758.87M | 741.02M | 651.59M | 755.89M | 884.71M | 1.10B |
| Total Debt | 2.26B | 2.45B | 2.79B | 2.72B | 1.29B | 1.23B |
| Total Liabilities | 3.64B | 3.88B | 4.25B | 4.48B | 2.30B | 2.21B |
| Stockholders Equity | 6.94B | 6.77B | 6.65B | 6.23B | 4.93B | 4.46B |
Cash Flow | ||||||
| Free Cash Flow | 509.49M | 466.39M | 92.02M | -157.98M | 92.26M | -236.84M |
| Operating Cash Flow | 904.68M | 949.98M | 707.13M | 782.84M | 685.38M | 426.25M |
| Investing Cash Flow | -521.43M | -412.62M | -671.09M | -2.86B | -372.06M | -850.85M |
| Financing Cash Flow | -524.41M | -476.79M | -216.56M | 1.78B | -154.21M | 754.50M |
Hygeia Healthcare Holdings Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6078, the sentiment is Negative. The current price of 9.51 is above the 20-day moving average (MA) of 9.45, below the 50-day MA of 9.76, and below the 200-day MA of 10.97, indicating a neutral trend. The MACD of -0.07 indicates Negative momentum. The RSI at 48.52 is Neutral, neither overbought nor oversold. The STOCH value of 70.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:6078.
Hygeia Healthcare Holdings Co., Ltd. Peers Comparison
Overall Rating
HK:330966Neutral- HK:607862Neutral
HK:663948Neutral
HK:195145Neutral
HK:388641Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:3309 | 66Neutral | HKD 1.05B | 10.10 | 5.57% | 2.35% | 4.75% | ― |
| HK:6078 | 62Neutral | HKD 5.84B | 27.81 | 2.55% | ― | 1.59% | -58.55% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:6639 | 48Neutral | HKD 1.03B | 31.06 | 1.27% | ― | ― | ― |
| HK:1951 | 45Neutral | HKD 6.11B | 26.75 | 1.87% | 1.84% | 6.52% | ― |
| HK:3886 | 41Neutral | HKD 1.10B | 78.09 | 0.48% | 1.10% | -3.26% | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:6078 | Hygeia Healthcare Holdings Co., Ltd. | 9.51 | -3.88 | -29.01% | |
| HK:1951 | Jinxin Fertility Group Ltd. | 2.27 | -0.16 | -6.47% | |
| HK:3309 | C-MER Eye Care Holdings Limited | 0.85 | -0.91 | -51.81% | |
| HK:3886 | Town Health International Medical Group Ltd. | 0.16 | -0.11 | -40.07% | |
| HK:6639 | Arrail Group Ltd. | 1.83 | -0.09 | -4.74% |
Hygeia Healthcare Holdings Co., Ltd. Corporate Events
Hygeia Healthcare Lifts Profit, Boosts Cash Flow and Unveils Expanded Shareholder Return Plan
Hygeia Healthcare reported interim revenue of RMB1,961.0 million for the six months ended June 30, 2026, a slight 1.4% decline year-on-year, while net profit rose 4.7% to RMB257.4 million and gross margin expanded to 27.4%. Operating cash generation...
Hygeia Healthcare to Present 2026 Interim Results via Investor Call
Hygeia Healthcare Holdings Co., Ltd. has announced it will host a conference call on August 28, 2026, to present its interim financial results and discuss its business operations in detail. The presentation aims to give shareholders and potential inv...
Hygeia Healthcare Sets Board Meeting to Approve Interim Results and Consider Dividend
Hygeia Healthcare Holdings Co., Ltd. has scheduled a board meeting for August 27, 2026 to review and approve the interim financial results for the six months ended June 30, 2026. The board will also consider the publication of these results and discu...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 29, 2026